(SBS) Companhia de Saneamento - NYSE
Sector: Utilities | Industry: Utilities - Regulated Water | Exchange: NYSE (USA) | Market Cap: 19.006m USD | Total Return: 34.1% in 12m
Avg Turnover: 33.1M
EPS Trend: -80.1%
Qual. Beats: 0
Rev. Trend: 83.9%
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
Companhia de Saneamento Básico do Estado de São Paulo (SABESP) operates as a large-scale utility providing water and sewage services across 375 municipalities in São Paulo State, Brazil. Founded in 1954, the company manages extensive infrastructure including millions of direct water and sewage connections alongside wholesale supply operations.
The business model relies on long-term concession agreements with municipal governments, which grant SABESP exclusive rights to operate regional sanitation networks. As a regulated utility, its revenue is primarily driven by tariff structures overseen by state regulatory agencies, reflecting the capital-intensive nature of the water services sector.
Investors can evaluate the company’s regulatory framework and dividend history further on ValueRay.
- Privatization execution and operational efficiency gains drive long-term valuation upside
- Regulatory tariff adjustments directly impact annual revenue growth and margins
- Brazilian Real volatility against the Dollar affects debt servicing costs
- Severe drought cycles increase operational expenses and limit water supply volume
- Infrastructure investment mandates require significant capital expenditure and debt financing
| Net Income: 8.53b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 6.50 > 1.0 |
| NWC/Revenue: 28.15% < 20% (prev 2.44%; Δ 25.70% < -1%) |
| CFO/TA 0.07 > 3% & CFO 8.02b > Net Income 8.53b |
| Net Debt (32.1b) to EBITDA (14.9b): 2.16 < 3 |
| Current Ratio: 1.74 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.52b) vs 12m ago 3.11% < -2% |
| Gross Margin: 36.07% > 18% (prev 48.69%; Δ -12.63% > 0.5%) |
| Asset Turnover: 38.06% > 50% (prev 52.01%; Δ -13.96% > 0%) |
| Interest Coverage Ratio: 2.34 > 6 (EBIT TTM 12.5b / Interest Expense TTM 5.36b) |
| A: 0.09 (Total Current Assets 25.6b - Total Current Liabilities 14.7b) / Total Assets 118b |
| B: 0.01 (Retained Earnings 1.25b / Total Assets 118b) |
| C: 0.12 (EBIT TTM 12.5b / Avg Total Assets 102b) |
| D: 0.58 (Book Value of Equity 43.2b / Total Liabilities 74.4b) |
| Altman-Z'' = 2.08 = BBB |
| DSRI: 1.73 (Receivables 6.31b/4.19b, Revenue 38.7b/44.6b) |
| GMI: 1.35 (GM 48.69% / 36.07%) |
| AQI: 0.93 (AQ_t 0.77 / AQ_t-1 0.83) |
| SGI: 0.87 (Revenue 38.7b / 44.6b) |
| TATA: 0.00 (NI 8.53b - CFO 8.02b) / TA 118b) |
| Beneish M = -2.24 (Cap -4..+1) = BBB |
As of June 12, 2026, the stock is trading at USD 5.47 with a total of 6,109,286 shares traded.
Over the past week, the price has changed by -0.36%,
over one month by -12.62%,
over three months by -3.98% and
over the past year by +34.09%.
Companhia de Saneamento has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy SBS.
- StrongBuy: 3
- Buy: 3
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 6.8 | 25% |
Market Cap BRL = 96.8b (19.0b USD * 5.0954 USD.BRL)
P/E Trailing = 11.0612
P/E Forward = 15.7233
P/S = 0.4796
P/B = 2.254
P/EG = 0.4697
Revenue TTM = 38.7b BRL
EBIT TTM = 12.5b BRL
EBITDA TTM = 14.9b BRL
Long Term Debt = 46.6b BRL (from longTermDebt, last quarter)
Short Term Debt = 4.62b BRL (from shortTermDebt, last quarter)
Debt = 51.1b BRL (from shortLongTermDebtTotal, last quarter) + Leases 266.7m
Net Debt = 32.1b BRL (calculated: Debt 51.1b - CCE 19.0b)
Enterprise Value = 129b BRL (96.8b + Debt 51.1b - CCE 19.0b)
Interest Coverage Ratio = 2.34 (Ebit TTM 12.5b / Interest Expense TTM 5.36b)
EV/FCF = 7.47x (Enterprise Value 129b / FCF TTM 17.3b)
FCF Yield = 13.38% (FCF TTM 17.3b / Enterprise Value 129b)
FCF Margin = 44.60% (FCF TTM 17.3b / Revenue TTM 38.7b)
Net Margin = 22.04% (Net Income TTM 8.53b / Revenue TTM 38.7b)
Gross Margin = 36.07% ((Revenue TTM 38.7b - Cost of Revenue TTM 24.7b) / Revenue TTM)
Gross Margin QoQ = 38.81% (prev 32.46%)
Tobins Q-Ratio = 1.10 (Enterprise Value 129b / Total Assets 118b)
Interest Expense / Debt = 10.50% (Interest Expense 5.36b / Debt 51.1b)
Taxrate = 26.05% (3.00b / 11.5b)
NOPAT = 9.27b (EBIT 12.5b * (1 - 26.05%))
Current Ratio = 1.74 (Total Current Assets 25.6b / Total Current Liabilities 14.7b)
Debt / Equity = 1.18 (Debt 51.1b / totalStockholderEquity, last quarter 43.2b)
Debt / EBITDA = 2.16 (Net Debt 32.1b / EBITDA 14.9b)
Debt / FCF = 1.86 (Net Debt 32.1b / FCF TTM 17.3b)
Total Stockholder Equity = 42.2b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.39% (Net Income 8.53b / Total Assets 118b)
RoE = 20.23% (Net Income TTM 8.53b / Total Stockholder Equity 42.2b)
RoCE = 14.11% (EBIT 12.5b / Capital Employed (Equity 42.2b + L.T.Debt 46.6b))
RoIC = 8.78% (NOPAT 9.27b / Invested Capital 106b)
WACC = 8.06% (E(96.8b)/V(148b) * Re(8.22%) + D(51.1b)/V(148b) * Rd(10.50%) * (1-Tc(0.26)))
Discount Rate = 8.22% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 43.53 | Cagr: 107.3%
[DCF] Terminal Value 77.97% ; FCFF base≈13.2b ; Y1≈15.1b ; Y5≈22.2b
[DCF] Fair Price = 86.07 (EV 334b - Net Debt 32.1b = Equity 302b / Shares 3.51b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -80.07 | EPS CAGR: -34.89% | SUE: -0.57 | # QB: 0
Revenue Correlation: 83.90 | Revenue CAGR: 27.07% | SUE: 0.71 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.08 | Chg30d=-7.49% | Revisions=-20% | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.09 | Chg30d=-7.56% | Revisions=-20% | Analysts=1
EPS current Year (2026-12-31): EPS=0.38 | Chg30d=+0.56% | Revisions=+0% | GrowthEPS=+8.4% | GrowthRev=+12.6%
EPS next Year (2027-12-31): EPS=0.55 | Chg30d=-7.30% | Revisions=-20% | GrowthEPS=+45.9% | GrowthRev=+19.2%
[Analyst] Revisions Ratio: -20%